375
Views
37
CrossRef citations to date
0
Altmetric
Review

An attempt to formulate an evidence-based strategy in the management of moderate-to-severe psoriasis: a review of the efficacy and safety of biologics and prebiologic options

, , &
Pages 617-632 | Published online: 22 Mar 2007

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Yajia Li, Ziqin Cao, Jia Guo, Qiangxiang Li, Wu Zhu, Yehong Kuang & Xiang Chen. (2022) Assessment of efficacy and safety of UV-based therapy for psoriasis: a network meta-analysis of randomized controlled trials. Annals of Medicine 54:1, pages 159-169.
Read now
Simon M. Mueller & Peter Itin. (2015) Phototherapy trends in dermatology – light or dark? Correspondence to phototherapy trends in dermatology by Luersen et al.. Journal of Dermatological Treatment 26:5, pages 489-490.
Read now
Gérald E Piérard, Claudine Piérard-Franchimont, Grégory Szepetiuk, Philippe Paquet & Pascale Quatresooz. (2010) The therapeutic potential of TNF-α antagonists for skin psoriasis comorbidities. Expert Opinion on Biological Therapy 10:8, pages 1197-1208.
Read now
Shilpa Gattu, Mei-Lin Pang, Rupa Pugashetti, Farah Malick, Judith Hong, Elyn Bowers, Jeffrey I. Levatter & John Koo. (2010) Pilot evaluation of supra-erythemogenic phototherapy with excimer laser in the treatment of patients with moderate to severe plaque psoriasis. Journal of Dermatological Treatment 21:1, pages 54-60.
Read now
Mei-Lin Pang, Jenny E Murase & John Koo. (2008) An updated review of acitretin – a systemic retinoid for the treatment of psoriasis. Expert Opinion on Drug Metabolism & Toxicology 4:7, pages 953-964.
Read now

Articles from other publishers (32)

Kristen M. Beck & John Koo. 2021. Advances in Psoriasis. Advances in Psoriasis 71 91 .
Michael Abrouk, Mio Nakamura, Tian Hao Zhu, Benjamin Farahnik, Rasnik K. Singh, Kristina M. Lee, Margareth V. Jose, John Koo, Tina Bhutani & Wilson Liao. (2016) The Patient’s Guide to Psoriasis Treatment. Part 3: Biologic Injectables. Dermatology and Therapy 6:3, pages 325-331.
Crossref
Tien V. Nguyen & John Y. M. Koo. 2014. Advances in Psoriasis. Advances in Psoriasis 91 110 .
Fahad Almutawa, Naif Alnomair, Yun Wang, Iltefat Hamzavi & Henry W. Lim. (2013) Systematic Review of UV-Based Therapy for Psoriasis. American Journal of Clinical Dermatology 14:2, pages 87-109.
Crossref
Argentina Leon, Wilson J. Liao, Rishu Gupta, John Y. M. Koo & Jashin J. Wu. (2018) Tumor Necrosis Factor-α Triad: Psoriasis, Cardiovascular Disease, and Depression. Psoriasis Forum 19a:1, pages 41-49.
Crossref
Ethan C. Levin, Rishu Gupta & Kanade Shinkai. (2018) Duration of Remission of Topical Psoriasis Therapies. Psoriasis Forum 19a:1, pages 22-33.
Crossref
Kenneth Gordon, Kim Papp, Yves Poulin, Yihua Gu, Stephen Rozzo & Eric H. Sasso. (2012) Long-term efficacy and safety of adalimumab in patients with moderate to severe psoriasis treated continuously over 3 years: Results from an open-label extension study for patients from REVEAL. Journal of the American Academy of Dermatology 66:2, pages 241-251.
Crossref
Steven R FeldmanLee Eric SHeller Misha MKamangar FaranakPark KellyKoo John YM. 2011. Current and Emerging Treatments for Psoriasis. Current and Emerging Treatments for Psoriasis 60 71 .
B. Pedro Lobos & L. Gonzalo Eguiguren. (2011) Piel en el siglo XXI. Revista Médica Clínica Las Condes 22:6, pages 713-721.
Crossref
J.-H. Saurat, R.G. Langley, K. Reich, K. Unnebrink, E.H. Sasso & W. Kampman. (2011) Relationship between methotrexate dosing and clinical response in patients with moderate to severe psoriasis: subanalysis of the CHAMPION study. British Journal of Dermatology 165:2, pages 399-406.
Crossref
Yukari OKUBO, Shoko NATSUME, Kae USUI, Misato AMAYA & Ryoji TSUBOI. (2011) Low-dose, short-term ciclosporin (Neoral®) therapy is effective in improving patients’ quality of life as assessed by Skindex-16 and GHQ-28 in mild to severe psoriasis patients. The Journal of Dermatology 38:5, pages 465-472.
Crossref
Janet E Angus, Ray Jobling, Hywel C Williams, Ingvil Saeterdal, Catherine Roberts & Elmer Villanueva. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Michael J. Murphy, Carlo Pincelli, Diane M. Hoss & Riccardo G. Borroni. 2011. Molecular Diagnostics in Dermatology and Dermatopathology. Molecular Diagnostics in Dermatology and Dermatopathology 419 441 .
Kristine Busse & John Koo. (2018) A Practical Approach to the Use of Methotrexate. Psoriasis Forum 16a:3, pages 48-59.
Crossref
Lenka Borska, Ctirad Andrys, Jan Krejsek, Kvetoslava Hamakova, Jan Kremlacek, Vladimir Palicka, Dianna Ranna & Zdenek Fiala. (2010) Genotoxic and apoptotic effects of Goeckerman therapy for psoriasis. International Journal of Dermatology 49:3, pages 289-294.
Crossref
Josep Manel Casanova, Verónica Sanmartín, Xavier Soria, Marta Ferran, Ramon M. Pujol & Miquel Ribera. (2009) Tratamiento tópico de la psoriasis. Piel 24:10, pages 556-567.
Crossref
Torello Lotti, Lara Tripo, Marta Grazzini, Alena Krysenka, Gionata Buggiani & Vincenzo De Giorgi. (2009) Focused UV-B narrowband microphototherapy (Biopsorin ® ). A new treatment for plaque psoriasis . Dermatologic Therapy 22:4, pages 383-385.
Crossref
Rebeca de Miguel & Rokea el-Azhary. (2009) Efficacy, safety, and cost of Goeckerman therapy compared with biologics in the treatment of moderate to severe psoriasis. International Journal of Dermatology 48:6, pages 653-658.
Crossref
CM Witt, R Lüdtke & SN Willich. (2009) Homeopathic treatment of patients with psoriasis - a prospective observational study with 2 years follow-up. Journal of the European Academy of Dermatology and Venereology 23:5, pages 538-543.
Crossref
L. Puig, X. Bordas, J.M. Carrascosa, E. Daudén, C. Ferrándiz, J.M. Hernanz, J.L. López-Estebaranz, J.C. Moreno, J.L. Sánchez-Carazo, F. Vanaclocha & H. Vázquez-Veiga. (2009) Consensus Document on the Evaluation and Treatment of Moderate to Severe Psoriasis. Spanish Psoriasis Group of the Spanish Academy of Dermatology and Venereology. Actas Dermo-Sifiliográficas (English Edition) 100:4, pages 277-288.
Crossref
L. Puig, X. Bordas, J.M. Carrascosa, E. Daudén, C. Ferrándiz, J.M. Hernanz, J.L. López-Estebaranz, J.C. Moreno, J.L. Sánchez-Carazo, F. Vanaclocha & H. Vázquez-Veiga. (2009) Documento de consenso sobre la evaluación y el tratamiento de la psoriasis moderada/grave del Grupo Español de Psoriasis de la Academia Española de Dermatología y Venereología. Actas Dermo-Sifiliográficas 100:4, pages 277-286.
Crossref
Carlo Pincelli, Marco Pignatti & Riccardo G. Borroni. (2009) Pharmacogenomics in dermatology: from susceptibility genes to personalized therapy. Experimental Dermatology 18:4, pages 337-349.
Crossref
A. Levy-Roy, R. Porcher, A.-L. de Fonclare, P. Morel & A. Dupuy. (2009) Efficacité des anti-TNF-α dans le psoriasis : revue systématique et représentation graphique. Annales de Dermatologie et de Vénéréologie 136:4, pages 315-322.
Crossref
M. Caproni, E. Antiga, L. Melani, W. Volpi, E. Del Bianco & P. Fabbri. (2008) Serum Levels of IL-17 and IL-22 Are Reduced by Etanercept, but not by Acitretin, in Patients with Psoriasis: a Randomized-Controlled Trial. Journal of Clinical Immunology 29:2, pages 210-214.
Crossref
Mark Chaballa, Joanne Filicko-O'Hara, Dorothy Holt, Adam M. Frank, John L. Wagner, Dolores Grosso & Neal Flomenberg. 2009. Pharmacology and Therapeutics. Pharmacology and Therapeutics 1269 1294 .
Mark R. Pittelkow & Joseph Genebriera. 2009. Pharmacology and Therapeutics. Pharmacology and Therapeutics 983 1005 .
Harald Gollnick. 2009. Braun-Falco’s Dermatology. Braun-Falco’s Dermatology 1573 1593 .
Sibel Ersoy-Evans, Aslı Altaykan, Sedef Şahin & Fikret Kölemen. (2008) Phototherapy in Childhood. Pediatric Dermatology 25:6, pages 599-605.
Crossref
Gianfranco Altomare, Fabio Ayala, Enzo Berardesca, Sergio Chimenti, Alberto Giannetti, Giampiero Girolomoni, Torello Lotti, Patrizia Martini, Andrea Peserico, Antonio Puglisi Guerra & Gino A. Vena. (2008) Etanercept provides a more physiological approach in the treatment of psoriasis. Dermatologic Therapy 21, pages S1-S14.
Crossref
Lenka Borska, Ctirad Andrys, Jan Krejsek, Kvetoslava Hamakova, Jan Kremlacek, Karel Ettler & Zdenek Fiala. (2008) Serum levels of the pro-inflammatory cytokine interleukin-12 and the anti-inflammatory cytokine interleukin-10 in patients with psoriasis treated by the Goeckerman regimen. International Journal of Dermatology 47:8, pages 800-805.
Crossref
. (2007) Current awareness: Pharmacoepidemiology and drug safety. Pharmacoepidemiology and Drug Safety 16:12.
Crossref
A MacDonald & A D Burden. (2007) Psoriasis: advances in pathophysiology and management. Postgraduate Medical Journal 83:985, pages 690-697.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.